venBio Global Strategic Fund III, L.P.

venBio Global Strategic Fund III, L.P. is listed in filings as 10% Owner at Artiva Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 22, 2024, including purchase activity. Recent filings connect the profile to Artiva Biotherapeutics, Inc. (ARTV). The current snapshot covers public activity from Jul 22, 2024. Reported amounts are shown as $2174.2B to $5.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.